Graziela Zibetti Dal Molin

4PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 15, 2026
Erdafitinib in Patients With Advanced Solid Tumors With FGFR Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.

|Dec 29, 2025
Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinoma.

Shubham Pant, Joon Oh Park, Wu-Chou Su

|Dec 04, 2019
Discrepancy in calculated and measured glomerular filtration rates in patients treated with PARP inhibitors.

Graziela Zibetti Dal Molin, Shannon Neville Westin, Pavlos Msaouel

|Jul 07, 2018
Rucaparib in ovarian cancer: an update on safety, efficacy and place in therapy.

Graziela Z Dal Molin, Kohei Omatsu, Anil K Sood

Pageof 1

Frequent Collaborators

2 joint publications

Shubham Pant

2 joint publications

Yohann Loriot

2 joint publications

Omar Carranza

2 joint publications

Marcelo Corassa